Your browser doesn't support javascript.
loading
Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease.
Margaroli, Camilla; Horati, Hamed; Garratt, Luke W; Giacalone, Vincent D; Schofield, Craig; Dittrich, A Susanne; Rosenow, Tim; Dobosh, Brian S; Lim, Hong S; Frey, Dario L; Veltman, Mieke; Silva, George L; Brown, Milton R; Schultz, Carsten; Tiddens, Harm A W M; Ranganathan, Sarath; Chandler, Joshua D; Qiu, Peng; Peng, Limin; Scholte, Bob J; Mall, Marcus A; Kicic, Anthony; Guglani, Lokesh; Stick, Stephen M; Janssens, Hettie M; Tirouvanziam, Rabindra.
Afiliación
  • Margaroli C; Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America.
  • Horati H; Department of Pediatrics, Div. of Respiratory Medicine and Allergology, I-BALL program, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, The Netherlands.
  • Garratt LW; AREST-CF Program, Telethon Kids Institute, University of Western Australia, Perth, Australia.
  • Giacalone VD; Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America.
  • Schofield C; AREST-CF Program, Telethon Kids Institute, University of Western Australia, Perth, Australia.
  • Dittrich AS; Department of Translational Pulmonology, Translational Lung Research Center (TLRC), German Center for Lung Research (DZL) and Department of Pulmonology, and Critical Care Medicine, Thoraxklinik at the University of Heidelberg, Heidelberg, Germany.
  • Rosenow T; AREST-CF Program, Telethon Kids Institute, University of Western Australia, Perth, Australia.
  • Dobosh BS; Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America.
  • Lim HS; Department of Biomedical engineering, The Georgia Institute of Technology and Emory University, Atlanta, GA, United States of America.
  • Frey DL; Department of Translational Pulmonology, Translational Lung Research Center (TLRC), German Center for Lung Research (DZL) and Department of Pulmonology, and Critical Care Medicine, Thoraxklinik at the University of Heidelberg, Heidelberg, Germany.
  • Veltman M; Department of Pediatrics, Div. of Respiratory Medicine and Allergology, I-BALL program, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, The Netherlands.
  • Silva GL; Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America.
  • Brown MR; Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America.
  • Schultz C; Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, OR, United States of America.
  • Tiddens HAWM; Department of Pediatrics, Div. of Respiratory Medicine and Allergology, I-BALL program, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, The Netherlands.
  • Ranganathan S; Department of Pediatrics, University of Melbourne, Melbourne, Australia; Murdoch Children's Research Institute, and Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Australia.
  • Chandler JD; Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America.
  • Qiu P; Department of Biomedical engineering, The Georgia Institute of Technology and Emory University, Atlanta, GA, United States of America.
  • Peng L; Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America; Department of Biostatistics, Emory University School of Public Health, Atlanta, GA, United States o
  • Scholte BJ; Department of Pediatrics, Div. of Respiratory Medicine and Allergology, I-BALL program, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, The Netherlands.
  • Mall MA; Department of Translational Pulmonology, Translational Lung Research Center (TLRC), German Center for Lung Research (DZL) and Department of Pulmonology, and Critical Care Medicine, Thoraxklinik at the University of Heidelberg, Heidelberg, Germany; Department of Pediatric Pulmonology, Immunology and
  • Kicic A; AREST-CF Program, Telethon Kids Institute, University of Western Australia, Perth, Australia; Department of Respiratory and Sleep Medicine, Perth Children's Hospital and Faculty of Medicine, University of Western Australia, Perth, Western Australia, Australia; School of Public Heath, Curtin Universi
  • Guglani L; Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America.
  • Stick SM; AREST-CF Program, Telethon Kids Institute, University of Western Australia, Perth, Australia; Department of Respiratory and Sleep Medicine, Perth Children's Hospital and Faculty of Medicine, University of Western Australia, Perth, Western Australia, Australia.
  • Janssens HM; Department of Pediatrics, Div. of Respiratory Medicine and Allergology, I-BALL program, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, The Netherlands.
  • Tirouvanziam R; Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America. Electronic address: tirouvanziam@emory.edu.
J Cyst Fibros ; 21(6): 967-976, 2022 11.
Article en En | MEDLINE | ID: mdl-35732550

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: J Cyst Fibros Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: J Cyst Fibros Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos